Donor immune cells target deadly EBV lymphoma in groundbreaking single-patient trial
NCT ID NCT06391814
First seen Mar 27, 2026 · Last updated May 13, 2026 · Updated 6 times
Summary
This trial tested a treatment for one young adult with a severe EBV-related lymphoma after a stem cell transplant. Doctors gave them specially grown immune cells from their donor to help control the disease and prevent it from coming back. The main goal was to check safety, especially avoiding graft-versus-host disease, while also monitoring the patient's recovery and virus levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBV ASSOCIATED LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ciusss-Emtl
Montreal, Quebec, H1T 2M4, Canada
Conditions
Explore the condition pages connected to this study.